英国男性使用睾酮替代疗法的经验和结果的横断面调查。

IF 1.7 3区 医学 Q4 ANDROLOGY
Translational andrology and urology Pub Date : 2025-05-30 Epub Date: 2025-05-27 DOI:10.21037/tau-2024-738
Austen El-Osta, Vivian N Liu, David Huang, Jeff Foster, Hans Johnson, Aos Alaa, Benedict Hayhoe
{"title":"英国男性使用睾酮替代疗法的经验和结果的横断面调查。","authors":"Austen El-Osta, Vivian N Liu, David Huang, Jeff Foster, Hans Johnson, Aos Alaa, Benedict Hayhoe","doi":"10.21037/tau-2024-738","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prevalence of late-onset testosterone deficiency (TD) ranges between 6-30% depending on diagnostic criteria. Recent data highlights various benefits of testosterone replacement therapy (TRT), including increased libido, mood, bone mineral density, and lean body mass. This study investigated the personal experiences of men with TD around low testosterone and TRT, including barriers to accessing TRT.</p><p><strong>Methods: </strong>Previous or current TRT users were recruited via email from private clinics' emailing lists, professional medical organisations and researchers' professional networks. Participants completed a 52-item structured questionnaire on Qualtrics XM, exploring their perceptions and experiences of TRT on their symptoms and quality of life. Associations between demographics, duration of symptoms and effectiveness were assessed using logistic regressions.</p><p><strong>Results: </strong>Among the 905 men on TD treatment, 86% delayed treatment for at least a year, including 24% who experienced symptoms for over 5 years before seeking care. Older men (aged 51+ years) were 1.61 times more likely to delay treatment. The majority (85%) reported TRT as effective or very effective, with longer-term users 2.6 times more likely to report TRT as very effective compared to recent starters. Primary motivations for seeking TRT included improving personal relationships (79%) and physical appearance (53%). Most (81%) relied on online sources for information; fewer (18%) felt comfortable discussing hormonal health with their peers. Patient expectations during medical consultations focused on diagnosis (77%), treatment options (64%) and learning about potential side effects (51%). The most common side effects were acne (24%), testicular shrinkage (24%) and nipple itchiness/gynaecomastia (19%). TRT users reported notable improvements in overall quality of life (75%), mental wellbeing (71%), self-esteem and self-confidence (69%) and appearance (61%).</p><p><strong>Conclusions: </strong>A significant proportion of men aged over 50 years surveyed reported experiencing prolonged symptoms of TD prior to seeking care. There is a need for greater awareness and education regarding TD symptoms, including streamlining timely and equitable access to effective treatment options.</p>","PeriodicalId":23270,"journal":{"name":"Translational andrology and urology","volume":"14 5","pages":"1295-1307"},"PeriodicalIF":1.7000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170005/pdf/","citationCount":"0","resultStr":"{\"title\":\"A cross-sectional survey of experiences and outcomes of using testosterone replacement therapy in UK men.\",\"authors\":\"Austen El-Osta, Vivian N Liu, David Huang, Jeff Foster, Hans Johnson, Aos Alaa, Benedict Hayhoe\",\"doi\":\"10.21037/tau-2024-738\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Prevalence of late-onset testosterone deficiency (TD) ranges between 6-30% depending on diagnostic criteria. Recent data highlights various benefits of testosterone replacement therapy (TRT), including increased libido, mood, bone mineral density, and lean body mass. This study investigated the personal experiences of men with TD around low testosterone and TRT, including barriers to accessing TRT.</p><p><strong>Methods: </strong>Previous or current TRT users were recruited via email from private clinics' emailing lists, professional medical organisations and researchers' professional networks. Participants completed a 52-item structured questionnaire on Qualtrics XM, exploring their perceptions and experiences of TRT on their symptoms and quality of life. Associations between demographics, duration of symptoms and effectiveness were assessed using logistic regressions.</p><p><strong>Results: </strong>Among the 905 men on TD treatment, 86% delayed treatment for at least a year, including 24% who experienced symptoms for over 5 years before seeking care. Older men (aged 51+ years) were 1.61 times more likely to delay treatment. The majority (85%) reported TRT as effective or very effective, with longer-term users 2.6 times more likely to report TRT as very effective compared to recent starters. Primary motivations for seeking TRT included improving personal relationships (79%) and physical appearance (53%). Most (81%) relied on online sources for information; fewer (18%) felt comfortable discussing hormonal health with their peers. Patient expectations during medical consultations focused on diagnosis (77%), treatment options (64%) and learning about potential side effects (51%). The most common side effects were acne (24%), testicular shrinkage (24%) and nipple itchiness/gynaecomastia (19%). TRT users reported notable improvements in overall quality of life (75%), mental wellbeing (71%), self-esteem and self-confidence (69%) and appearance (61%).</p><p><strong>Conclusions: </strong>A significant proportion of men aged over 50 years surveyed reported experiencing prolonged symptoms of TD prior to seeking care. There is a need for greater awareness and education regarding TD symptoms, including streamlining timely and equitable access to effective treatment options.</p>\",\"PeriodicalId\":23270,\"journal\":{\"name\":\"Translational andrology and urology\",\"volume\":\"14 5\",\"pages\":\"1295-1307\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170005/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational andrology and urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/tau-2024-738\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ANDROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational andrology and urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tau-2024-738","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:根据诊断标准,迟发性睾酮缺乏症(TD)的患病率在6-30%之间。最近的数据强调了睾酮替代疗法(TRT)的各种好处,包括提高性欲、情绪、骨密度和瘦体重。本研究调查了低睾酮和TRT对TD男性患者的个人经历,包括获得TRT的障碍。方法:通过电子邮件从私人诊所的电子邮件列表、专业医疗机构和研究人员的专业网络中招募以前或现在的TRT用户。参与者完成了一份包含52个项目的质量XM结构化问卷,探讨他们对TRT对其症状和生活质量的看法和体验。使用logistic回归评估人口统计学、症状持续时间和疗效之间的关系。结果:在905名接受TD治疗的男性中,86%的患者延迟治疗至少一年,其中24%的患者在就诊前症状已超过5年。老年男性(51岁以上)延迟治疗的可能性是老年男性的1.61倍。大多数(85%)报告TRT有效或非常有效,长期服用者报告TRT非常有效的可能性是最近开始服用者的2.6倍。寻求TRT的主要动机包括改善人际关系(79%)和外貌(53%)。大多数(81%)依赖在线信息来源;更少的人(18%)愿意与同龄人讨论荷尔蒙健康问题。患者在医疗咨询期间的期望主要集中在诊断(77%)、治疗方案(64%)和了解潜在的副作用(51%)。最常见的副作用是痤疮(24%)、睾丸萎缩(24%)和乳头瘙痒/女性乳房增生(19%)。TRT使用者报告在总体生活质量(75%)、心理健康(71%)、自尊和自信(69%)以及外表(61%)方面有显著改善。结论:在接受调查的50岁以上的男性中,有相当大比例的人在寻求治疗之前经历了长期的TD症状。有必要提高对TD症状的认识和教育,包括简化及时和公平获得有效治疗方案的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A cross-sectional survey of experiences and outcomes of using testosterone replacement therapy in UK men.

A cross-sectional survey of experiences and outcomes of using testosterone replacement therapy in UK men.

Background: Prevalence of late-onset testosterone deficiency (TD) ranges between 6-30% depending on diagnostic criteria. Recent data highlights various benefits of testosterone replacement therapy (TRT), including increased libido, mood, bone mineral density, and lean body mass. This study investigated the personal experiences of men with TD around low testosterone and TRT, including barriers to accessing TRT.

Methods: Previous or current TRT users were recruited via email from private clinics' emailing lists, professional medical organisations and researchers' professional networks. Participants completed a 52-item structured questionnaire on Qualtrics XM, exploring their perceptions and experiences of TRT on their symptoms and quality of life. Associations between demographics, duration of symptoms and effectiveness were assessed using logistic regressions.

Results: Among the 905 men on TD treatment, 86% delayed treatment for at least a year, including 24% who experienced symptoms for over 5 years before seeking care. Older men (aged 51+ years) were 1.61 times more likely to delay treatment. The majority (85%) reported TRT as effective or very effective, with longer-term users 2.6 times more likely to report TRT as very effective compared to recent starters. Primary motivations for seeking TRT included improving personal relationships (79%) and physical appearance (53%). Most (81%) relied on online sources for information; fewer (18%) felt comfortable discussing hormonal health with their peers. Patient expectations during medical consultations focused on diagnosis (77%), treatment options (64%) and learning about potential side effects (51%). The most common side effects were acne (24%), testicular shrinkage (24%) and nipple itchiness/gynaecomastia (19%). TRT users reported notable improvements in overall quality of life (75%), mental wellbeing (71%), self-esteem and self-confidence (69%) and appearance (61%).

Conclusions: A significant proportion of men aged over 50 years surveyed reported experiencing prolonged symptoms of TD prior to seeking care. There is a need for greater awareness and education regarding TD symptoms, including streamlining timely and equitable access to effective treatment options.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
5.00%
发文量
80
期刊介绍: ranslational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, bi-monthly journal (quarterly published from Mar.2012 - Dec. 2014). The main focus of the journal is to describe new findings in the field of translational research of Andrology and Urology, provides current and practical information on basic research and clinical investigations of Andrology and Urology. Specific areas of interest include, but not limited to, molecular study, pathology, biology and technical advances related to andrology and urology. Topics cover range from evaluation, prevention, diagnosis, therapy, prognosis, rehabilitation and future challenges to urology and andrology. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信